BioAscent Discovery

#BioAscent Discovery #Drug discovery

Opportunity knocks: why high quality leads matter

Does every cloud have a silver lining? Dr Phil Jones, Chief Scientific Officer, BioAscent Discovery outlines the opportunities for lead generation and the acquisition of compound screening libraries. The discovery of novel medicines is a complex but vital endeavour. The range of approaches being used to identify those new medicines… Read More

#Business & Investment